Feb 12, 2025 · Enhertu is a treatment for breast cancer, advanced stomach cancer, non-small cell lung cancer, and solid tumors with HER2 gene mutations in certain patients. Enhertu may help people with cancer live longer and delay the progression of their disease. Enhertu is both a chemotherapy drug and a targeted therapy.

have breast cancer that has come back during or within 6 months of completing treatment for their early-stage breast cancer. whose disease has returned during or within 6 months of completing adjuvant chemotherapy (after surgery). Your healthcare provider will perform a test to make sure ENHERTU is right for you.

NCCN Guidelines ® lists fam-trastuzumab deruxtecan-nxki (ENHERTU) as a treatment option for multiple metastatic solid tumors. See the NCCN Guidelines for detailed information.

Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) can be used to treat unresectable or metastatic HER2-positive breast cancer.

Jan 31, 2025 · Enhertu is an infusion given into your vein (IV) by your healthcare provider. What is Enhertu used for? Enhertu (fam-trastuzumab deruxtecan-nxki) is commonly used for treating different...

Trastuzumab deruxtecan, sold under the brand name Enhertu, is an antibody-drug conjugate consisting of the humanized monoclonal antibody trastuzumab (Herceptin) covalently linked to the topoisomerase I inhibitor deruxtecan (a derivative of exatecan). [11][12] It is licensed for the treatment of breast cancer or gastric or gastroesophageal adenoc...

ENHERTU is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive (IHC 3+ or ISH positive) breast cancer who have received a prior anti-HER2-based regimen either: in the neoadjuvant or adjuvant setting and have developed disease recurrence during or within six months of completing therapy.

Jul 2, 2024 · Enhertu is a brand-name intravenous (IV) infusion prescribed for certain types of HER2-positive cancers and HER2-low breast cancer. Enhertu contains the active ingredient fam-trastuzumab...

Aug 5, 2024 · Enhertu (fam-trastuzumab deruxtecan-nxki) is used to treat adults with certain cancers that have a protein called HER2 on tumor cells. These cancers include breast cancer, non-small cell lung cancer (NSCLC), stomach cancer, esophageal cancer, and other solid tumors.

Learn about the side effects of Enhertu (fam-trastuzumab deruxtecan), from common to rare, for consumers and healthcare professionals.